Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study on the Impact of Rejuvenated Autologous Blood Transfusion on VO2 Max in Healthy Subjects

NCT03089047 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03089047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03089047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study on the Impact of Rejuvenated Autologous Blood Transfusion on VO2 Max in Healthy Subjects
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Terminated
Start date
September 29, 2017
Completion date
April 18, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythrocyte transfusion